Boots Healthcare Intl.
This article was originally published in The Tan Sheet
Executive Summary
UK retailer/manufacturer to use Bioprogress Technology's XGel soft capsule system under deal announced Nov. 28. Separately, Boots appoints Chuo Bussan Intl. as distributor for Clearasil in Japan, effective Dec. 3. BHI expects to expand Clearasil distribution in 130 countries where Boots products are sold. Line likely will be extended in fiscal 2002 to address greater range of skin conditions, such as psoriasis, firm says. Boots, which purchased Clearasil from P&G last year, recently named Novartis as distributor in U.S. and Canada (1"The Tan Sheet" May 21, In Brief)...